About the DAIDS RSC Safety Team
The DAIDS RSC Safety Team receives expedited adverse events (EAEs) reported by Clinical Research Sites (CRSs) participating in DAIDS-supported studies, processes the events for review by the DAIDS Medical Officer, and prepares the reports for submission to the Food and Drug Administration (FDA). The DAIDS RSC Safety Team works closely with the Office for Policy in Clinical Research Operations (OPCRO) Safety and Pharmacovigilance Team (SPT) to establish internal procedures and develop training on safety and EAE reporting to DAIDS for the CRSs.
Content last reviewed on